SCHEMBL20161851

SCHEMBL20161851

CNC(=O)c1cc(Sc2cnc(NC=O)s2)c(C)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 18/20 0.53
BTK Q06187 16/20 0.53
TXK P42681 15/20 0.53
ITK Q08881 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24467238 0.87 JAK3 (0.66) JAK3BTKTXKITK
SCHEMBL24467153 0.85 JAK3 (0.48) JAK3BTKTXKITK
SCHEMBL24467260 0.83 ITK (0.72) JAK3BTKTXKITK
SCHEMBL20161423 0.83 JAK3 (0.47) JAK3BTKTXKITK
SCHEMBL23366064 0.79 JAK3 (0.82) JAK3BTKTXKITK
SCHEMBL24467233 0.78 JAK3 (0.66) JAK3BTKTXKITK
SCHEMBL24467227 0.77 JAK3 (0.67) JAK3BTKTXKITK
SCHEMBL20161771 0.77 JAK3 (0.65) JAK3BTKTXKITK
SCHEMBL20162002 0.76 TXK (0.66) JAK3BTKTXKITK
SCHEMBL20161769 0.76 JAK3 (0.67) JAK3BTKTXKITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3534899-B1 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS INC (US) 2022-06-01 EP disclosed
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed